You are here: Industry Insights > Pfizer

News List

Pfizer's palbociclib most commonly used breast cancer drug in clinical trials pharmafile
December 12, 2018
The drug, which was used in 4% of breast cancer clinical trials conducted in 2018, was investigated for its use as a combination therapy in the vast majority of cases.
Pfizer UK names new managing director pharmatimes
December 11, 2018
Pfizer has announced the appointment of Ben Osborn as managing director in the UK, taking over from Erik Nordkamp, who will now become general manager UK and cluster lead Europe within Pfizer’s Established Medicines business.
On a roll with FDA approvals, Pfizer doubles down in AML with Daurismo nod fiercepharma
December 10, 2018
Make that four drug approvals for Pfizer’s oncology unit in less than two months. In a welcome streak for the pharma giant—what with Lyrica generics looming—the FDA handed out
Pfizer reaches a global agreement with AbbVie worldpharmanews
December 06, 2018
Pfizer Inc. (NYSE:PFE) has signed licensing agreements with AbbVie, resolving all global intellectual property matters for Pfizer's proposed adalimumab biosimilar.
Pfizer wins blockbuster Lyrica patent extension to safeguard sales till June fiercepharma
December 06, 2018
Pfizer, looking to protect billions in Lyrica sales, has been gunning for a 6-month pediatric exclusivity extension for its top drug. And on Tuesday, the FDA came through in favor of the drugmaker.
AbbVie inks Humira patent deal No. 7, delaying Pfizer's U.S. biosim launch until late 2023 fiercepharma
December 05, 2018
AbbVie is on a hot streak striking patent deals to protect its top drug, Humira. Even as Boehringer Ingelheim has opted to fight the company’s patent claims in court
AbbVie, Pfizer reach licencing agreement for biosimilar Humira pharmaphorum
December 04, 2018
AbbVie has granted a non-exclusive patent license allowing Pfizer to sell its Humira (adalimumab) biosimilar in many countries around the world.....
Pfizer strikes deal with Chinese online pharmacy Jianke pharmaphorum
December 04, 2018
Pfizer is set to implement a new retail, hospital services and internet healthcare strategy in China as part of a deal with local online pharmacy and health services platform Jianke.
Pfizer secures Humira licence agreements with AbbVie pharmaceutical-technology
December 04, 2018
Pfizer has resolved licensing issues regarding its adalimumab biosimilar that was deemed too close to AbbVie’s Humira (adalimumab).....
AbbVie Announces Humira Global Patent License with Pfizer americanpharmaceuticalreview
December 03, 2018
AbbVie announced patent license agreements with Pfizer over its proposed biosimilar adalimumab product. Under the terms of the agreements.....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page